Company News

FDA in India Serves Notice to Wipro

Author Image

By: TOM BRANNA

Editor

MUMBAI: The Maharashtra Food and Drug Administration (FDA) served a notice to Wipro for allegedly “misbranding and mislabeling” its baby oil. “We have served notice to Wipro for misbranding and labeling deficiency or mislabeling its baby oil manufactured under the name Wipro Baby Soft,” FDA commissioner A. Ramkrishnan said....

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters